See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In an unprecedented large-scale study, researchers have mapped out the ...
After studying 140,000 versions of the Aβ42 peptide, scientists identified some of the earliest molecular interactions that drive the formation of harmful amyloid protein aggregates found in Alzheimer ...
Morning Overview on MSN
The Alzheimer’s protein Sox9 works by waking up astrocytes and activating a receptor called MEGF10 that eats amyloid plaques
For decades, Alzheimer’s research has centered on neurons, the brain cells that die as the disease progresses, and on the sticky amyloid-beta plaques that accumulate between them. A study published in ...
Cerebral amyloid angiopathy is a major cause of hemorrhagic stroke, a frequent contributor to age-related cognitive impairment, and a key component in adverse responses to beta-amyloid (Aβ) ...
Patients with Alzheimer’s disease on amyloid-targeting therapy had less cognitive decline when their baseline amyloid burden ...
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new review in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results